# GeneMedicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genemedicine-2

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.gene-medicine.com
- Total disclosed funding: $43M
- Latest round: Series B (Jul 29, 2021)
- Investors on record: 10

## About

Founded in 2014 and based in Seoul, South Korea, Genemedicine operates as a biotechnology company that develops anti-cancer drugs based on adenovirus genetic manipulation technologies. In August 2024, GeneMedicine raised KRW 13.2 billion in series C funding from new investor BNC Korea, with participation from other investors, valuing the company at KRW 69.45 billion post-money.

GeneMedicine offers a pipeline of potential treatments, with ongoing research and development efforts focused on various types of cancer. Their research content covers a wide range of areas, including viral vector design, optimization of delivery mechanisms, and clinical trials. In addition to its R&D activities, GeneMedicine also operates a Contract Development and Manufacturing Organization (CDMO/CMO) business. This division provides services to other pharmaceutical and biotechnology companies, offering expertise in viral vector production and process development.

The company will utilize the series C funding in August 2024 to expand its oncology and gene-therapy pipeline, scale its CDMO and drug-delivery platform, and strengthen the business foundation needed for its planned KOSDAQ listing.

## Funding rounds

- Series B, Jul 29, 2021, $30M — KB Investment, Atinum Investment, IMM Investment, Posco Investment, Winvest Venture Capital, L&C Bio, Korea Asset Investment Securities
- Series A, May 18, 2019, $14M — LB Investment, Atinum Investment, SV Investment, Albatross Investment, Winvest Venture Capital

## Investors

- LB Investment (https://capitalatlas.ai/funds/lb-investment) — Series A
- Atinum Investment (https://capitalatlas.ai/funds/atinum-investment) — Series A, Series B
- SV Investment (https://capitalatlas.ai/funds/sv-investment) — Series A
- Albatross Investment (https://capitalatlas.ai/funds/albatross-investment) — Series A
- Winvest Venture Capital (https://capitalatlas.ai/funds/winvest-venture-capital) — Series A, Series B
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B
- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Series B
- L&C Bio — Series B
- Korea Asset Investment Securities (https://capitalatlas.ai/funds/korea-asset-investment-securities) — Series B